Home » Hospira Recalls Dobutamine Injection
Hospira Recalls Dobutamine Injection
Injectable drugmaker Hospira has issued a voluntary recall of dobutamine injection, USP, after a customer complaint of discoloration in a single vial of the heart disease drug.
Drug Industry Daily
Drugs Quality Regulatory AffairsDrug Industry Daily
Upcoming Events
-
14May
-
23May
-
30May
-
20Jun
-
21Oct